308 related articles for article (PubMed ID: 24262450)
21. Octreotide: a therapeutic option for idiopathic intracranial hypertension.
Panagopoulos GN; Deftereos SN; Tagaris GA; Gryllia M; Kounadi T; Karamani O; Panagiotidis D; Koutiola-Pappa E; Karageorgiou CE; Piadites G
Neurol Neurophysiol Neurosci; 2007 Jul; ():1. PubMed ID: 17700925
[TBL] [Abstract][Full Text] [Related]
22. Pediatric idiopathic intracranial hypertension (pseudotumor cerebri).
Ko MW; Liu GT
Horm Res Paediatr; 2010; 74(6):381-9. PubMed ID: 20962512
[TBL] [Abstract][Full Text] [Related]
23. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center.
Galvin JA; Van Stavern GP
J Neurol Sci; 2004 Aug; 223(2):157-60. PubMed ID: 15337617
[TBL] [Abstract][Full Text] [Related]
24. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri.
Baykan B; Ekizoğlu E; Altıokka Uzun G
Agri; 2015; 27(2):63-72. PubMed ID: 25944131
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.
Shah VA; Kardon RH; Lee AG; Corbett JJ; Wall M
Neurology; 2008 Feb; 70(8):634-40. PubMed ID: 18285538
[TBL] [Abstract][Full Text] [Related]
26. Primary spontaneous cerebrospinal fluid rhinorrhea: a symptom of idiopathic intracranial hypertension?
Yang Z; Wang B; Wang C; Liu P
J Neurosurg; 2011 Jul; 115(1):165-70. PubMed ID: 21476806
[TBL] [Abstract][Full Text] [Related]
27. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri).
Johnson LN; Krohel GB; Madsen RW; March GA
Ophthalmology; 1998 Dec; 105(12):2313-7. PubMed ID: 9855165
[TBL] [Abstract][Full Text] [Related]
28. [Benign childhood intracranial hypertension].
Orssaud C; Dureau P; Zerah M; Cinalli G; Sainte Rose C; Kahn AP; Dufier JL
J Fr Ophtalmol; 2001 Jan; 24(1):54-9. PubMed ID: 11240472
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics of Idiopathic Intracranial Hypertension in Patients Over 50 Years of Age: A multicenter clinical cohort study.
Downie PA; Chen JJ; Bhatti MT; Melson AT; Van Stavern GP; McClelland CM; Lindgren BR; Sharieff JA; Lee MS
Am J Ophthalmol; 2021 Apr; 224():96-101. PubMed ID: 33253662
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic idiopathic intracranial hypertension in young children.
Weig SG
J Child Neurol; 2002 Mar; 17(3):239-41. PubMed ID: 12026246
[TBL] [Abstract][Full Text] [Related]
31. Clinical and Prognostic Significance of Cerebrospinal Fluid Opening and Closing Pressures in Pediatric Pseudotumor Cerebri Syndrome.
Beres SJ; Sheldon CA; Boisvert CJ; Szperka CL; Paley GL; Burrows EK; Chilutti MR; Liu GW; McCormack SE; Liu GT
Pediatr Neurol; 2018 Jun; 83():50-55. PubMed ID: 29753572
[TBL] [Abstract][Full Text] [Related]
32. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension.
Radojicic A; Vukovic-Cvetkovic V; Pekmezovic T; Trajkovic G; Zidverc-Trajkovic J; Jensen RH
J Neurol Sci; 2019 Apr; 399():89-93. PubMed ID: 30782528
[TBL] [Abstract][Full Text] [Related]
33. Predictors of disease course and long-term outcomes of idiopathic intracranial hypertension in children and adolescents.
Senderowich N; Bachar-Zipori A; Mitelpunkt A; Latzer IT; Klein A; Mezad-Koursh D; Fattal-Valevski A; Hausman-Kedem M
Eur J Pediatr; 2023 Nov; 182(11):5137-5147. PubMed ID: 37691042
[TBL] [Abstract][Full Text] [Related]
34. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
Knoche T; Gaus V; Haffner P; Kowski A
Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
[TBL] [Abstract][Full Text] [Related]
35. Concomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.
Tavakoli M; Yan F; Tauscher R
J AAPOS; 2024 Feb; 28(1):103806. PubMed ID: 38216114
[TBL] [Abstract][Full Text] [Related]
36. Pseudotumor cerebri in pediatric age: role of obesity in the management of neurological impairments.
Marton E; Feletti A; Mazzucco GM; Longatti P
Nutr Neurosci; 2008 Feb; 11(1):25-31. PubMed ID: 18510800
[TBL] [Abstract][Full Text] [Related]
37. [Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients].
Rodríguez de Rivera FJ; Martínez-Sanchez P; Ojeda-Ruiz de Luna J; Arpa-Gutiérrez FJ; Barreiro-Tella P
Rev Neurol; 2003 Nov 1-15; 37(9):801-5. PubMed ID: 14606044
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic intracranial hypertension: pseudotumor cerebri.
Kosmorsky GS
Headache; 2014 Feb; 54(2):389-93. PubMed ID: 24512582
[TBL] [Abstract][Full Text] [Related]
39. [Idiopathic intracranial hypertension and tetracycline].
Weller B; Sharf B; Sierpinski-Barth J; Schwartz M
Harefuah; 1994 Jul; 127(1-2):9-11, 64. PubMed ID: 7959395
[TBL] [Abstract][Full Text] [Related]
40. Post dural puncture headache in a pediatric patient with idiopathic intracranial hypertension.
Nafiu OO; Monterosso D; Walton SR; Bradin S
Paediatr Anaesth; 2005 Sep; 15(9):778-81. PubMed ID: 16101710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
